LVW Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$584K Sell
1,164
-110
-9% -$52.8K 0.05% 211
2026
Q1
$626K Buy
1,274
+379
+42% +$206K 0.06% 175
2025
Q4
$519K Buy
895
+160
+22% +$90.5K 0.05% 183
2025
Q3
$356K Buy
735
+23
+3% +$10.7K 0.04% 251
2025
Q2
$289K Sell
712
-179
-20% -$74.8K 0.03% 269
2025
Q1
$443K Buy
891
+2
+0.2% +$1.08K 0.05% 190
2024
Q4
$462K Sell
889
-21
-2% -$11.5K 0.06% 201
2024
Q3
$563K Sell
910
-43
-5% -$25.5K 0.07% 176
2024
Q2
$527K Buy
953
+4
+0.4% +$2.29K 0.08% 162
2024
Q1
$552K Sell
949
-56
-6% -$31.4K 0.09% 156
2023
Q4
$533K Buy
1,005
+150
+18% +$72.6K 0.1% 144
2023
Q3
$433K Sell
855
-16
-2% -$8.53K 0.09% 141
2023
Q2
$454K Sell
871
-23
-3% -$12.4K 0.09% 134
2023
Q1
$515K Sell
894
-12
-1% -$6.76K 0.1% 140
2022
Q4
$499K Sell
906
-29
-3% -$15.4K 0.1% 147
2022
Q3
$474K Buy
935
+21
+2% +$11.8K 0.11% 137
2022
Q2
$497K Buy
914
+71
+8% +$39.1K 0.1% 139
2022
Q1
$498K Buy
843
+24
+3% +$13.8K 0.08% 148
2021
Q4
$546K Sell
819
-532
-39% -$332K 0.09% 143
2021
Q3
$772K Sell
1,351
-48
-3% -$26.3K 0.13% 115
2021
Q2
$706K Buy
1,399
+34
+2% +$16K 0.13% 117
2021
Q1
$623K Buy
1,365
+188
+16% +$89.7K 0.12% 125
2020
Q4
$548K Buy
1,177
+555
+89% +$260K 0.11% 110
2020
Q3
$275K Sell
622
-398
-39% -$164K 0.06% 160
2020
Q2
$370K Buy
+1,020
New +$342K 0.09% 116

Other funds holding TMO

LVW Advisors's TMO Position: Q2 2026 in Review

LVW Advisors reduced its Thermo Fisher Scientific (TMO) stake by 8.6% in Q2 2026, selling an estimated $52.8K and leaving 1,164 shares worth $584K. The position accounts for 0.05% of the portfolio, ranked #211.

LVW Advisors first reported a position in TMO in Q2 2020 and has held it in 25 quarters since. The position peaked at $772K in Q3 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • LVW Advisors held 1,164 shares of Thermo Fisher Scientific worth $584K as of Q2 2026.
  • LVW Advisors sold 110 Thermo Fisher Scientific shares in Q2 2026, an estimated $52.8K.
  • Thermo Fisher Scientific made up 0.05% of LVW Advisors's portfolio in Q2 2026, its #211 holding.
  • LVW Advisors first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 25 quarters since.
  • LVW Advisors's Thermo Fisher Scientific position peaked at $772K in Q3 2021.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.